The Jordanian Pharmaceutical Manufacturing Co. Plc. Reports Earnings Results for the First Quarter Ended March 31, 2019

Jordanian Pharmaceutical Manufacturing Co PSC (JPM) is a Jordan-based public shareholding company engaged in the manufacture and distribution of medicine, chemical, cosmetic, and pharmaceutical products. The Company is also involved in the trade of medical appliances. JPM's pharmaceutical preparations include tablets, capsules, suppositories, Injectables, syrups and suspensions. Its generic pharmaceutical division covers a range of therapeutic categories, including Cardiovascular, Gastrointestinal, Central Nervous System, Anti-Infective, Endocrine, Musculoskeletal, Respiratory, Obstetrics, Gynecology & Urinary Tract, and Immune System. As of December 31, 2011, the Company's subsidiaries included wholly owned Dallas Company for Natural Products and Sawagh Pharmaceutical and Food Industries Company; 99.66%-owned Algerian Jordanian Pharmaceutical Company, and 67%-owned Arajan Biotechnology Company and Kdna Medical Co.